No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs566833074 |
chr11:58872798-58872799 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs373727222 |
chr11:58872801-58872802 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs377025493 |
chr11:58872814-58872815 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs534064103 |
chr11:58872818-58872819 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs555794395 |
chr11:58872860-58872861 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs567368503 |
chr11:58872937-58872938 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs10896919 |
chr11:58872960-58872961 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs556508114 |
chr11:58872962-58872963 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs185153184 |
chr11:58872964-58872965 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs190344845 |
chr11:58872965-58872966 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs553516611 |
chr11:58872972-58872973 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs560021414 |
chr11:58872976-58872977 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs571993046 |
chr11:58872984-58872985 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs528763889 |
chr11:58872989-58872990 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs552016520 |
chr11:58872997-58872998 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs542374356 |
chr11:58873003-58873004 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs560990298 |
chr11:58873004-58873005 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs529453776 |
chr11:58873019-58873020 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs182031764 |
chr11:58873073-58873074 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs562739643 |
chr11:58873114-58873115 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs187462769 |
chr11:58873124-58873125 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs552032710 |
chr11:58873129-58873130 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs565359548 |
chr11:58873157-58873158 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs527655028 |
chr11:58873163-58873164 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs552806592 |
chr11:58873180-58873181 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs376851845 |
chr11:58873262-58873263 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs530965563 |
chr11:58873273-58873274 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs113199129 |
chr11:58873321-58873322 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs188164337 |
chr11:58873341-58873342 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs548119557 |
chr11:58873373-58873374 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs550270476 |
chr11:58873397-58873398 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs567014302 |
chr11:58873398-58873399 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs185537031 |
chr11:58873431-58873432 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs571445344 |
chr11:58873449-58873450 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs538969895 |
chr11:58873481-58873482 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs201533773 |
chr11:58873491-58873492 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs112454387 |
chr11:58873492-58873493 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs375249838 |
chr11:58873494-58873495 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs190199131 |
chr11:58873497-58873498 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs143149154 |
chr11:58873522-58873523 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs571968961 |
chr11:58873566-58873567 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs183460057 |
chr11:58873623-58873624 |
Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs143499813 |
chr11:58873648-58873649 |
Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs575778569 |
chr11:58873688-58873689 |
Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs34816453 |
chr11:58873703-58873704 |
Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs543091258 |
chr11:58873730-58873731 |
Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs562773457 |
chr11:58873761-58873762 |
Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs546168638 |
chr11:58873833-58873834 |
Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs186672335 |
chr11:58873872-58873873 |
Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs566794128 |
chr11:58873879-58873880 |
Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|